Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.
Any time a firm needs to save money, high-salaried executives are targets
Give the cool 20% of your audience cool stuff, like apps. Relate to the other 80% in ways that are less cool
A level of trust happens when you have an in-person relationship that just can't be recreated online
In an era when many patients prefer a conversation over a commercial, and as the FDA considers revisions to the "brief summary," how much risk information is necessary in DTC ads and why?
Hospira is taking to the courts to fight off generic threats to its hospital sedation drug Precedex
Ben Ingersoll, Chief creative officer, ghg
Meredith Mae Roberts, Senior Copywriter, HCB Health
A charge of sexism against the FDA clouds the views surrounding a drug's application
Click on the image at the left to see a gallery of images from the 2013 MM&M Awards dinner
*Group discounts available on request
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.